MKLN1 and hepatocellular carcinoma: Clinically, knockdown of muskelin 1 antisense RNA (MKLN1-AS), a lncRNA that is associated with vascular invasion and poor prognosis and is upregulated in HCC tissues, enhances the pro-apoptotic effects of lenvatinib, and thus, could be used as a therapeutic target [207].